Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
Conditions
Astrocytoma, IDH-Mutant · Glioblastoma · Glioma · Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Study leads
Ugur T. Sener, MD
Principal Investigator
Mayo Clinic
Tufia C. Haddad, MD
Principal Investigator
Mayo Clinic
No study contact email or phone is listed for this trial.